News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

RECOVER scientists, study participants, and Representatives are working together to make new discoveries about Long COVID and how to diagnose, prevent, and treat its symptoms.
As RECOVER’s adult observational study moves to the next phase, researchers continue to explore the various causes of common Long COVID symptoms, such as difficulty breathing.
At the RECOVER Research Review (R3) Seminar held on April 14, RECOVER researchers presented findings on how Long COVID affects the brain, including difficulties with thinking clearly, memory, and concentration. They also outlined future research opportunities to better understand neurocognitive symptoms and how other body systems impact brain health.
RECOVER researchers are continuing plans to explore cognitive symptoms like brain fog in the initiative’s adult observational study, one of the most common but least understood symptoms of Long COVID.
RECOVER recognizes International Long COVID Awareness Day on March 15—a day established by the Long COVID community to increase visibility of the condition, share resources, and educate the public.
Recent RECOVER publications include findings about possible causes of and treatments for Long COVID.
During the February 10, 2026, RECOVER Research Review (R3) Seminar, RECOVER researchers Sarah Donohue, PhD, MPH, and Tanayott (Tony) Thaweethai, PhD, presented research on Long COVID trajectories in adults. Published in November 2025, this research—which includes participants from the initiative’s adult observational cohort study—explores different clinical presentations of Long COVID and how the condition progresses over time. RECOVER Patient Representative and co-author Mady Hornig, MD, MA, and Timothy Henrich, MD, MMSc, a Long COVID researcher, also shared their perspectives and experiences.
RECOVER marks 5 years of Long COVID research, with NIH leaders, scientists, and clinicians continuing to guide and advance the initiative’s mission. In 2026, RECOVER will expand clinical trials to find answers for the Long COVID community.